In agreement with our findings, HMGCS2 was previously reported to be significantly down-regulated in HCC patients with high alpha-fetoprotein (AFP), tumor size >5 cm, multinodular, advanced tumor staging including BCLC, TNM and CLIP [32]. The gene discussed is HMGCS2; the disease is hepatocellular carcinoma.